Literature DB >> 15638824

Comprehensive cystic fibrosis mutation epidemiology and haplotype characterization in a southern Italian population.

G Castaldo1, A Polizzi, R Tomaiuolo, C Cazeneuve, E Girodon, T Santostasi, D Salvatore, V Raia, N Rigillo, M Goossens, F Salvatore.   

Abstract

We screened the whole coding region of the cystic fibrosis transmembrane regulator (CFTR) gene in 371 unrelated cystic fibrosis (CF) patients from three regions of southern Italy. Forty-three mutations detected 91.5% of CF mutated chromosomes by denaturing gradient gel electrophoresis analysis, and three intragenic CFTR polymorphisms predicted a myriad of rare mutations in uncharacterized CF chromosomes. Twelve mutations are peculiar to CF chromosomes from southern Italy: R1158X, 4016insT, L1065P and 711 + 1G > T are present in 6.3% of CF chromosomes in Campania; G1244E and 852del22 are present in 9.6% of CF chromosomes in Basilicata and 4382delA, 1259insA, I502T, 852del22, 4016insT, D579G, R1158X, L1077P and G1349D are frequent in Puglia (19.6% of CF alleles). Several mutations frequently found in northern Italy (e.g., R1162X, 711 + 5G > T) and northern Europe (e.g., G551D, I507del and 621 + 1G > T) are absent from the studied population. The I148T-3195del6 complex allele was present in two CF chromosomes, whereas I148T was present in both alleles (as a single mutation) in another CF patient and in five CF carriers; this could result from crossover events. The haplotype analysis of three intragenic polymorphisms (IVS8CA, IVS17bTA and IVS17bCA) compared with data from other studies revealed that several mutations (3849 + 10kbC > T, 1717-1G > A, E585X, 3272-26G > A, L558S, 2184insA and R347P) originated from multiple events, whereas others (R1158X and S549R) could be associated with one or more intragenic recombinant events. Given the large population migration from southern Italy, knowledge of the CF molecular epidemiology in this area is an important contribution to diagnosis, counselling and interlaboratory quality control for molecular laboratories worldwide.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15638824     DOI: 10.1046/j.1529-8817.2004.00130.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  12 in total

1.  Inhibition of p38 mitogen activated protein kinase controls airway inflammation in cystic fibrosis.

Authors:  V Raia; L Maiuri; C Ciacci; I Ricciardelli; L Vacca; S Auricchio; M Cimmino; M Cavaliere; M Nardone; A Cesaro; J Malcolm; S Quaratino; M Londei
Journal:  Thorax       Date:  2005-06-30       Impact factor: 9.139

2.  Prenatal screening of Cystic Fibrosis: a single centre experience.

Authors:  Domenico Bizzoco; Alvaro Mesoraca; Antonella Cima; Monica Sarti; Gianluca Di Giacomo; Giovanna Scerra; Maria Antonietta Barone; Manuela Di Natale; Ivan Gabrielli; Caterina Tamburino; Claudia Scargiali; Cristina Ernandez; Maria Pia D'Aleo; Michele Todini; Rita Pompili; Luisa Mobili; Lucia Mangiafico; Ornella Carcioppolo; Claudio Coco; Pietro Cignini; Laura D'Emidio; Alessandra Girgenti; Cristiana Brizzi; Alessandro Cavaliere; Claudio Giorlandino
Journal:  J Prenat Med       Date:  2008-01

3.  Recurrent episodes of unexplained hypoelectrolytaemia of a rare cause in a young Saudi girl.

Authors:  Mohsen Suliaman Al-Atawi; Sulaiman Abdullah Al-Queflie; Hamad Abdullah Al-Sadoon
Journal:  BMJ Case Rep       Date:  2015-10-22

4.  Genotype-phenotype correlation in cystic fibrosis patients bearing [H939R;H949L] allele.

Authors:  Angela Polizzi; Riccardina Tesse; Teresa Santostasi; Anna Diana; Antonio Manca; Vito Paolo Logrillo; Maria Domenica Cazzato; Maria Giuseppa Pantaleo; Lucio Armenio
Journal:  Genet Mol Biol       Date:  2011-07-01       Impact factor: 1.771

Review 5.  Genetic diseases that predispose to early liver cirrhosis.

Authors:  Manuela Scorza; Ausilia Elce; Federica Zarrilli; Renato Liguori; Felice Amato; Giuseppe Castaldo
Journal:  Int J Hepatol       Date:  2014-07-14

6.  S737F is a new CFTR mutation typical of patients originally from the Tuscany region in Italy.

Authors:  Vito Terlizzi; Antonella Miriam Di Lullo; Marika Comegna; Claudia Centrone; Elisabetta Pelo; Giuseppe Castaldo; Valeria Raia; Cesare Braggion
Journal:  Ital J Pediatr       Date:  2018-01-03       Impact factor: 2.638

7.  Gene mutation in microRNA target sites of CFTR gene: a novel pathogenetic mechanism in cystic fibrosis?

Authors:  Felice Amato; Manuela Seia; Sonia Giordano; Ausilia Elce; Federica Zarrilli; Giuseppe Castaldo; Rossella Tomaiuolo
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

8.  Phenotypic expression of the p.Leu1077Pro CFTR mutation in Sicilian cystic fibrosis patients.

Authors:  Giuseppe Fabio Parisi; Silvia Cutello; Giovanna Di Dio; Novella Rotolo; Mario La Rosa; Salvatore Leonardi
Journal:  BMC Res Notes       Date:  2013-11-13

Review 9.  An update on laboratory diagnosis of liver inherited diseases.

Authors:  Federica Zarrilli; Ausilia Elce; Manuela Scorza; Sonia Giordano; Felice Amato; Giuseppe Castaldo
Journal:  Biomed Res Int       Date:  2013-10-08       Impact factor: 3.411

10.  Analysis of cystic fibrosis gene mutations in children with cystic fibrosis and in 964 infertile couples within the region of Basilicata, Italy: a research study.

Authors:  Domenico Dell'Edera; Michele Benedetto; Gemma Gadaleta; Domenico Carone; Donatello Salvatore; Antonella Angione; Massimiliano Gallo; Michele Milo; Maria Laura Pisaturo; Giuseppe Di Pierro; Eleonora Mazzone; Annunziata Anna Epifania
Journal:  J Med Case Rep       Date:  2014-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.